Shares of Apricus tank after FDA declines to OK erectile dysfunction cream

(Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news